MELA Sciences (MELA) Misses Q2 EPS by 66c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. AMAT
6. NRIX
7. SUNS
8. CRDO
9. OIG
10. SPY

Go back to MELA Sciences (MELA) Misses Q2 EPS by 66c

MELA Sciences Reports Second Quarter 2015 Financial Results

August 13, 2015 4:01 PM EDT

HORSHAM, Pa., Aug. 13, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ: MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, today reported financial results for the second quarter ended June 30, 2015.

Second Quarter and Recent Corporate Highlights

XTRAC and VTRAC businesses of PhotoMedex, Inc. purchased on June 22, 2015, for $42.5 million in cash and the assumption of certain business-related liabilities. Installed base of XTRAC systems in the U.S. expands to 664 systems placed, up from 554 at the end of the... More